Clinical trials
Completed Fallopian Tube Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
418 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 9 |
| 2001 | 12 |
| 2002 | 14 |
| 2003 | 19 |
| 2004 | 18 |
| 2005 | 18 |
| 2006 | 21 |
| 2007 | 21 |
| 2008 | 13 |
| 2009 | 20 |
| 2010 | 38 |
| 2011 | 26 |
| 2012 | 22 |
| 2013 | 12 |
| 2014 | 13 |
| 2015 | 13 |
| 2016 | 23 |
| 2017 | 20 |
| 2018 | 15 |
| 2019 | 17 |
| 2020 | 8 |
| 2021 | 8 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 418 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 52 |
| Gynecologic Oncology Group | 24 |
| Memorial Sloan Kettering Cancer Center | 24 |
| M.D. Anderson Cancer Center | 16 |
| AGO Study Group | 10 |
| Mayo Clinic | 8 |
| Eli Lilly and Company | 7 |
| Roswell Park Cancer Institute | 7 |
| AstraZeneca | 6 |
| Dana-Farber Cancer Institute | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 418 |
| Ovarian Neoplasms | 335 |
| Carcinoma, Ovarian Epithelial | 168 |
| Endometrial Neoplasms | 54 |
| Uterine Cervical Neoplasms | 44 |
| Neoplasms | 36 |
| Breast Neoplasms | 35 |
| Peritoneal Neoplasms | 34 |
| Vulvar Neoplasms | 28 |
| Vaginal Neoplasms | 27 |
Trials
Showing 51 to 75 of 418. Each trial links to its page on Pharma Observatory.
318 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.